The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO WCGIC 2020 | CAIRO6: perioperative systemic therapy for resectable colorectal peritoneal metastases
Ignace H.J.T. de Hingh MD, PhD and Koen Rovers, MD, of the Catharina Hospital, Eindhoven, The Netherlands, discuss the outcomes of the CAIRO6 study (NCT02758951), evaluating safety, feasibility, tolerability, and preliminary efficacy of perioperative systemic therapy for resectable colorectal peritoneal metastases. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).
